Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Moodys
Express Scripts
Mallinckrodt
Medtronic

Last Updated: January 31, 2023

Details for Patent: 10,040,872


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which drugs does patent 10,040,872 protect, and when does it expire?

Patent 10,040,872 protects EVOMELA and is included in one NDA.

This patent has twenty-eight patent family members in nineteen countries.

Summary for Patent: 10,040,872
Title:Alkylated cyclodextrin compositions and processes for preparing and using the same
Abstract: The present invention related to low-chloride alkylated cyclodextrin compositions, along with processes for preparing and using the same. The processes of the present invention provide alkylated cyclodextrins with low levels of drug-degrading agents and chloride.
Inventor(s): Antle; Vincent D. (Olathe, KS), Lopes; lvaro (Loures, PT), Monteiro; Daniel (Loures, PT)
Assignee: CyDex Pharmaceuticals, Inc. (San Diego, CA)
Application Number:14/437,439
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,040,872
Patent Claim Types:
see list of patent claims
Use; Composition; Process;

Drugs Protected by US Patent 10,040,872

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Acrotech Biopharma EVOMELA melphalan hydrochloride POWDER;INTRAVENOUS 207155-001 Mar 10, 2016 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,040,872

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2013334921 See Plans and Pricing
Brazil 112015008954 See Plans and Pricing
Canada 2888822 See Plans and Pricing
Chile 2015001016 See Plans and Pricing
Chile 2016003320 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Merck
McKesson
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.